ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0315

Identification of Calcium Crystals in End-Stage Osteoarthritis with Raman Spectroscopy

Tom Niessink1, Tim Welting2, Matthijs Janssen3, Cees Otto4 and Tim Jansen5, 1University of Twente, Utrecht, Netherlands, 2MUMC+, Maastricht, Netherlands, 3Viecuri MC / Venlo, Wijgmaal, Belgium, 4University of Twente, Enschede, Netherlands, 5VieCuri MC, Venlo, Netherlands

Meeting: ACR Convergence 2023

Keywords: Crystal-induced arthritis, Imaging, Osteoarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0308–0324) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Calcium containing crystals in osteoarthritis (OA) are of interest as they potentially stimulate the NRLP-3 inflammasome and may become treatable with novel therapeutics. Previous studies demonstrated a presence of calcium pyrophosphate (CPP) and basic calcium phosphate (BCP) crystals in early and advanced OA [1]. Calcium carbonate crystals have been found in cartilage specimens of advanced OA and have recently been shown to potentially occur early in development of cartilage calcification [2].

Methods: Synovial fluid samples from advanced knee OA cases were collected pre-operatively from the Maastricht University Medical Center (MUMC+). The population includes both males and females and all patients were above 18 years of age. Patients gave written informed consent before collection of their synovial fluid. Samples were analyzed with an integrated Raman polarized light microscope. Samples were considered positive for a certain type of crystal if at least one crystal with a distinctive spectrum could be identified.

Results: Calcium containing crystals were present in all (100%) of the 36 samples. 34 (94.4%) of the samples contained calcite (calcium carbonate) crystals. Dolomite (calcium magnesium carbonate) crystals were present in 10 (27.8%) samples, 9 (25.0%) samples contained both types of calcium carbonate crystals. CPP crystals were present in 33.3% of samples. Basic calcium phosphate crystals were present in 9 (25.0%) samples, all of which were hydroxyapatite. Calcium oxalate crystals were present in 7 (19.4%) samples, 3 of which were identified as calcium oxalate dihydrate (COD) and 4 of which were identified as calcium oxalate monohydrate. Most of the samples (80.6%) contained more than one type of calcium crystal, but CPP and BCP were never identified simultaneously in one sample. Raman spectra of identified particles are shown in figure 1.

Conclusion: Calcium containing crystals are common in synovial fluid samples from knee joints in patients with end-stage osteoarthritis. Raman spectroscopy is a novel technique for rheumatology which enables reliable detection and objective identification of crystals such as calcium carbonate. The observation of calcium carbonate (calcite) crystals in synovial fluids of OA patients is novel and a promising subject of further study. Pathways to presentation in synovial fluid and inflammatory properties should be investigated.

References:
1. Rosenthal, A.K., Crystals, inflammation, and osteoarthritis. Curr Opin Rheumatol, 2011. 23(2): p. 170-3.
2. Casal-Beiroa, P., V. Balboa-Barreiro, N. Oreiro, et al., Optical Biomarkers for the Diagnosis of Osteoarthritis through Raman Spectroscopy: Radiological and Biochemical Validation Using Ex Vivo Human Cartilage Samples. Diagnostics (Basel), 2021. 11(3).

Supporting image 1

Raman spectra of identified calcium containing crystals.


Disclosures: T. Niessink: None; T. Welting: Chondropeptix, 8, 10; M. Janssen: HCR B.V., 8; C. Otto: Hybriscan Technologies B.V., 8; T. Jansen: HCR B.V., 8.

To cite this abstract in AMA style:

Niessink T, Welting T, Janssen M, Otto C, Jansen T. Identification of Calcium Crystals in End-Stage Osteoarthritis with Raman Spectroscopy [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/identification-of-calcium-crystals-in-end-stage-osteoarthritis-with-raman-spectroscopy/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-calcium-crystals-in-end-stage-osteoarthritis-with-raman-spectroscopy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology